Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine if omega-3 polyunsaturated fatty acids
reduce atrial fibrillation and other outcomes after cardiac surgery. In this
placebo-controlled trial, patients undergoing elective coronary artery bypass graft surgery
with or without valve repair will be treated with omega-3 polyunsaturated fatty acids
perioperatively. The following hypotheses will be tested: 1. omega-3 polyunsaturated fatty
acids reduces the incidence of atrial fibrillation (AF) after cardiac surgery, 2. omega-3
polyunsaturated fatty acids, administered in the perioperative period for cardiac surgery,
decreases postoperative complication rates, and 3. omega-3 polyunsaturated fatty acids
decrease intensive care unit and hospital length-of-stay.